Anti-Inflammatory Drugs (NSAIDs)-Europe Market Status and Trend Report 2013-2023

February 2018 | 148 pages | ID: A07B5F14A48EN
MIReports Co., Limited

Abstracts

Report Summary

Anti-Inflammatory Drugs (NSAIDs)
-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Anti-Inflammatory Drugs (NSAIDs)
industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole Europe and Regional Market Size of Anti-Inflammatory Drugs (NSAIDs)
2013-2017, and development forecast 2018-2023
Main market players of Anti-Inflammatory Drugs (NSAIDs)
in Europe, with company and product introduction, position in the Anti-Inflammatory Drugs (NSAIDs)
market
Market status and development trend of Anti-Inflammatory Drugs (NSAIDs)
by types and applications
Cost and profit status of Anti-Inflammatory Drugs (NSAIDs)
, and marketing status
Market growth drivers and challenges

The report segments the Europe Anti-Inflammatory Drugs (NSAIDs)
market as:

Europe Anti-Inflammatory Drugs (NSAIDs)
Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

Germany
United Kingdom
France
Italy
Spain
Benelux
Russia

Europe Anti-Inflammatory Drugs (NSAIDs)
Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

Corticosteroids
Others

Europe Anti-Inflammatory Drugs (NSAIDs)
Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Hosptical
Pharmacy
Other

Europe Anti-Inflammatory Drugs (NSAIDs)
Market: Players Segment Analysis (Company and Product introduction, Anti-Inflammatory Drugs (NSAIDs)
Sales Volume, Revenue, Price and Gross Margin):

AbbVie
Amgen
AstraZeneca
Eli Lily
GlaxoSmithKline
Roche
Johnson & Johnson
Merck
Novartis
Pfizer

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Contents

CHAPTER 1 OVERVIEW OF ANTI-INFLAMMATORY DRUGS (NSAIDS)

1.1 Definition of Anti-Inflammatory Drugs (NSAIDs) in This Report
1.2 Commercial Types of Anti-Inflammatory Drugs (NSAIDs)
  1.2.1 Anti-inflammatory Biologics
  1.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  1.2.3 Corticosteroids
  1.2.4 Others
1.3 Downstream Application of Anti-Inflammatory Drugs (NSAIDs)
  1.3.1 Hosptical
  1.3.2 Pharmacy
  1.3.3 Other
1.4 Development History of Anti-Inflammatory Drugs (NSAIDs)
1.5 Market Status and Trend of Anti-Inflammatory Drugs (NSAIDs) 2013-2023
  1.5.1 Europe Anti-Inflammatory Drugs (NSAIDs) Market Status and Trend 2013-2023
  1.5.2 Regional Anti-Inflammatory Drugs (NSAIDs) Market Status and Trend 2013-2023

CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Anti-Inflammatory Drugs (NSAIDs) in Europe 2013-2017
2.2 Consumption Market of Anti-Inflammatory Drugs (NSAIDs) in Europe by Regions
  2.2.1 Consumption Volume of Anti-Inflammatory Drugs (NSAIDs) in Europe by Regions
  2.2.2 Revenue of Anti-Inflammatory Drugs (NSAIDs) in Europe by Regions
2.3 Market Analysis of Anti-Inflammatory Drugs (NSAIDs) in Europe by Regions
  2.3.1 Market Analysis of Anti-Inflammatory Drugs (NSAIDs) in Germany 2013-2017
  2.3.2 Market Analysis of Anti-Inflammatory Drugs (NSAIDs) in United Kingdom 2013-2017
  2.3.3 Market Analysis of Anti-Inflammatory Drugs (NSAIDs) in France 2013-2017
  2.3.4 Market Analysis of Anti-Inflammatory Drugs (NSAIDs) in Italy 2013-2017
  2.3.5 Market Analysis of Anti-Inflammatory Drugs (NSAIDs) in Spain 2013-2017
  2.3.6 Market Analysis of Anti-Inflammatory Drugs (NSAIDs) in Benelux 2013-2017
  2.3.7 Market Analysis of Anti-Inflammatory Drugs (NSAIDs) in Russia 2013-2017
2.4 Market Development Forecast of Anti-Inflammatory Drugs (NSAIDs) in Europe 2018-2023
  2.4.1 Market Development Forecast of Anti-Inflammatory Drugs (NSAIDs) in Europe 2018-2023
  2.4.2 Market Development Forecast of Anti-Inflammatory Drugs (NSAIDs) by Regions 2018-2023

CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES

3.1 Whole Europe Market Status by Types
  3.1.1 Consumption Volume of Anti-Inflammatory Drugs (NSAIDs) in Europe by Types
  3.1.2 Revenue of Anti-Inflammatory Drugs (NSAIDs) in Europe by Types
3.2 Europe Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Germany
  3.2.2 Market Status by Types in United Kingdom
  3.2.3 Market Status by Types in France
  3.2.4 Market Status by Types in Italy
  3.2.5 Market Status by Types in Spain
  3.2.6 Market Status by Types in Benelux
  3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Anti-Inflammatory Drugs (NSAIDs) in Europe by Types

CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Anti-Inflammatory Drugs (NSAIDs) in Europe by Downstream Industry
4.2 Demand Volume of Anti-Inflammatory Drugs (NSAIDs) by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Anti-Inflammatory Drugs (NSAIDs) by Downstream Industry in Germany
  4.2.2 Demand Volume of Anti-Inflammatory Drugs (NSAIDs) by Downstream Industry in United Kingdom
  4.2.3 Demand Volume of Anti-Inflammatory Drugs (NSAIDs) by Downstream Industry in France
  4.2.4 Demand Volume of Anti-Inflammatory Drugs (NSAIDs) by Downstream Industry in Italy
  4.2.5 Demand Volume of Anti-Inflammatory Drugs (NSAIDs) by Downstream Industry in Spain
  4.2.6 Demand Volume of Anti-Inflammatory Drugs (NSAIDs) by Downstream Industry in Benelux
  4.2.7 Demand Volume of Anti-Inflammatory Drugs (NSAIDs) by Downstream Industry in Russia
4.3 Market Forecast of Anti-Inflammatory Drugs (NSAIDs) in Europe by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ANTI-INFLAMMATORY DRUGS (NSAIDS)

5.1 Europe Economy Situation and Trend Overview
5.2 Anti-Inflammatory Drugs (NSAIDs) Downstream Industry Situation and Trend Overview

CHAPTER 6 ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE

6.1 Sales Volume of Anti-Inflammatory Drugs (NSAIDs) in Europe by Major Players
6.2 Revenue of Anti-Inflammatory Drugs (NSAIDs) in Europe by Major Players
6.3 Basic Information of Anti-Inflammatory Drugs (NSAIDs) by Major Players
  6.3.1 Headquarters Location and Established Time of Anti-Inflammatory Drugs (NSAIDs) Major Players
  6.3.2 Employees and Revenue Level of Anti-Inflammatory Drugs (NSAIDs) Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 ANTI-INFLAMMATORY DRUGS (NSAIDS) MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 AbbVie
  7.1.1 Company profile
  7.1.2 Representative Anti-Inflammatory Drugs (NSAIDs) Product
  7.1.3 Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin of AbbVie
7.2 Amgen
  7.2.1 Company profile
  7.2.2 Representative Anti-Inflammatory Drugs (NSAIDs) Product
  7.2.3 Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin of Amgen
7.3 AstraZeneca
  7.3.1 Company profile
  7.3.2 Representative Anti-Inflammatory Drugs (NSAIDs) Product
  7.3.3 Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin of AstraZeneca
7.4 Eli Lily
  7.4.1 Company profile
  7.4.2 Representative Anti-Inflammatory Drugs (NSAIDs) Product
  7.4.3 Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin of Eli Lily
7.5 GlaxoSmithKline
  7.5.1 Company profile
  7.5.2 Representative Anti-Inflammatory Drugs (NSAIDs) Product
  7.5.3 Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
7.6 Roche
  7.6.1 Company profile
  7.6.2 Representative Anti-Inflammatory Drugs (NSAIDs) Product
  7.6.3 Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin of Roche
7.7 Johnson & Johnson
  7.7.1 Company profile
  7.7.2 Representative Anti-Inflammatory Drugs (NSAIDs) Product
  7.7.3 Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.8 Merck
  7.8.1 Company profile
  7.8.2 Representative Anti-Inflammatory Drugs (NSAIDs) Product
  7.8.3 Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin of Merck
7.9 Novartis
  7.9.1 Company profile
  7.9.2 Representative Anti-Inflammatory Drugs (NSAIDs) Product
  7.9.3 Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin of Novartis
7.10 Pfizer
  7.10.1 Company profile
  7.10.2 Representative Anti-Inflammatory Drugs (NSAIDs) Product
  7.10.3 Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin of Pfizer

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANTI-INFLAMMATORY DRUGS (NSAIDS)

8.1 Industry Chain of Anti-Inflammatory Drugs (NSAIDs)
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ANTI-INFLAMMATORY DRUGS (NSAIDS)

9.1 Cost Structure Analysis of Anti-Inflammatory Drugs (NSAIDs)
9.2 Raw Materials Cost Analysis of Anti-Inflammatory Drugs (NSAIDs)
9.3 Labor Cost Analysis of Anti-Inflammatory Drugs (NSAIDs)
9.4 Manufacturing Expenses Analysis of Anti-Inflammatory Drugs (NSAIDs)

CHAPTER 10 MARKETING STATUS ANALYSIS OF ANTI-INFLAMMATORY DRUGS (NSAIDS)

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference